About MicroTransponder
MicroTransponder is a company based in Dallas (United States) founded in 2007 by Navzer Engineer and Jordan Curnes.. MicroTransponder has raised $180.45 million across 25 funding rounds from investors including HHS, USVP and Osage University Partners. The company has 33 employees as of December 31, 2022. MicroTransponder offers products and services including Vivistim Paired VNS System. MicroTransponder operates in a competitive market with competitors including Conformal Medical, Perfuze, MIVI Neuroscience, Wallaby Medical and Enspire DBS Therapy, among others.
- Headquarter Dallas, United States
- Employees 33 as on 31 Dec, 2022
- Founders Navzer Engineer, Jordan Curnes
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$180.45 M (USD)
in 25 rounds
-
Latest Funding Round
$65 M (USD), Series F
Mar 05, 2025
-
Investors
HHS
& 10 more
-
Employee Count
33
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MicroTransponder
MicroTransponder offers a comprehensive portfolio of products and services, including Vivistim Paired VNS System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Stimulates vagus nerve during therapy to aid stroke patient motor recovery.
Unlock access to complete
Funding Insights of MicroTransponder
MicroTransponder has successfully raised a total of $180.45M across 25 strategic funding rounds. The most recent funding activity was a Series F round of $65 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 25
- Last Round Series F — $65.0M
-
First Round
First Round
(19 Feb 2008)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Series F - MicroTransponder | Valuation | USVP | |
| Jun, 2022 | Amount | Series E - MicroTransponder | Valuation | USVP | |
| Sep, 2020 | Amount | Debt – Conventional - MicroTransponder | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MicroTransponder
MicroTransponder has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, USVP and Osage University Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm that focuses on early stage investments in the US
|
Founded Year | Domain | Location | |
|
Early- to growth-stage startups are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Stage-agnostic investments in US life sciences are pursued.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MicroTransponder
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MicroTransponder
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Microtransponder Comparisons
Competitors of MicroTransponder
MicroTransponder operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Conformal Medical, Perfuze, MIVI Neuroscience, Wallaby Medical and Enspire DBS Therapy, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Stroke prevention device for atrial fibrillation patients is developed.
|
|
| domain | founded_year | HQ Location |
A medical device for acute ischemic stroke treatment is developed.
|
|
| domain | founded_year | HQ Location |
Catheters and devices for acute ischemic stroke treatment are developed.
|
|
| domain | founded_year | HQ Location |
A medical device for stroke treatment is developed.
|
|
| domain | founded_year | HQ Location |
Stroke recovery therapy is developed via deep brain stimulation.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Microtransponder
Frequently Asked Questions about MicroTransponder
When was MicroTransponder founded?
MicroTransponder was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Where is MicroTransponder located?
MicroTransponder is headquartered in Dallas, United States. It is registered at Dallas, Texas, United States.
Who is the current CEO of MicroTransponder?
Richard Foust is the current CEO of MicroTransponder.
Is MicroTransponder a funded company?
MicroTransponder is a funded company, having raised a total of $180.45M across 25 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $5.75M, raised on Feb 19, 2008.
How many employees does MicroTransponder have?
As of Dec 31, 2022, the latest employee count at MicroTransponder is 33.
What does MicroTransponder do?
MicroTransponder was founded in 2007 in Dallas, United States, as a spin-out from the University of Texas at Dallas. Medical devices in the neuroscience sector are developed, with operations centered on two neurostimulation platforms. An implanted vagus nerve stimulator is created for tinnitus treatment and post-stroke motor rehabilitation. The wireless SAINT System addresses chronic pain management. Clinical trials are planned to evaluate both platforms for neurological disorders.
Who are the top competitors of MicroTransponder?
MicroTransponder's top competitors include Perfuze, Conformal Medical and MIVI Neuroscience.
What products or services does MicroTransponder offer?
MicroTransponder offers Vivistim Paired VNS System.
Who are MicroTransponder's investors?
MicroTransponder has 11 investors. Key investors include HHS, USVP, Osage University Partners, Action Potential Venture Capital, and Green Park & Golf Ventures.